Medtronic Hugo™ Robotic Assisted Surgery (RAS) System in Urologic Surgery (Expand URO)
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 144 participants.
Also called NCT05696444
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 144 participants
- Sponsor
- Registry
-
NCT05696444
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Results first posted
- Countries
- United States
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT05696444. Allocation not applicable; no masking; primary purpose treatment. Start 2022-12-14 (actual); primary completion 2024-10-10 (actual). Results posted on 2025-11-25.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Medtronic Hugo™ Robotic Assisted Surgery (RAS) System in Urologic Surgery (Expand URO)
- Condition
- Bladder Cancer
- Condition
- Prostate Cancer
- Condition
- Kidney Cancer
- Condition
- Pelvic Tumor
- Condition
- Interstitial Cystitis
- Condition
- Congenital Abnormalities
- Condition
- End Stage Renal Disease
- Condition
- Renal Tumor
- Condition
- Kidney Injury
- Intervention (Device)
- RAS Prostatectomy
- Intervention (Device)
- RAS Cystectomy
- Intervention (Device)
- RAS Nephrectomy
- Lead sponsor
- Medtronic - MITG
Record details
- Record id
cardio:ct-nct05696444- Content hash
53b61428095022b92bd0fac2fe1b302bc79818301c36fa18e91dbb9f33744193